期刊文献+

以重度ED为首发症状的垂体泌乳素瘤4例报告

Pituitary prolactinoma with severe erectile dysfunction as the initial symptom: Diagnosis and treatment of 4 cases
下载PDF
导出
摘要 目的:以重度ED为首发症状的垂体泌乳素瘤易误诊,分析该病所致重度ED的特点,以提高诊治水平。方法:回顾4例以重度ED(IIEF-5评分5~7分)为首发临床症状、经MRI检查确诊的垂体泌乳素瘤,结合文献诊治特点进行分析。结果:4例因垂体泌乳素瘤引起的重度ED误诊时间长达2年,血清泌乳素(PRL)均为正常高值的10倍以上,开始应用PDE5抑制剂无效,3例行单鼻孔-蝶窦-垂体瘤全切除术,术后24个月随访:1例PRL正常,IIEF-5 19分,2例PRL分别降至600和768 IU/L,IIEF-5均为15分,此时再服用PDE5抑制剂获得满意效果;1例口服溴隐亭保守治疗,12个月后随访PRL正常,IIEF-5>21分。结论:检测血PRL和脑MRI检查可以确诊以重度ED为首发临床症状的垂体泌乳素瘤,在PRL极高的情况下,单纯应用PDE5抑制剂无效,通过手术或药物降低PRL后,ED症状可改善,若改善不明显,此时再应用PDE5抑制剂将会收到满意的效果。 Objective: Pituitary prolactinoma with severe erectile dysfunction (ED) as the initial symptom is often misdiag- nosed. This article explores the diagnosis and treatment of severe ED caused by pituitary prolactinoma. Methods : We retrospectively analyzed the diagnosis and treatment of 4 cases of pituitary prolactinoma with severe ED ( IIEF-5 score 5 - 7 ) as the initial clinical symptom confirmed by MRI. Results: The 4 cases of pituitary prolactinoma-induced severe ED, with serum prolactin 10 times above the maximum normal level, were misdiagnosed for 2 years. All failed to respond to the PDE5 inhibitor therapy, and then 3 of them un- derwent transnasal hypophysiectomy. Twenty-four months of follow-up found the level of prolactin restored to normal in 1 case (IIEF-5 = 19), and reduced to 600 and 768 IU/L respectively ( IIEF-5 = 15) in the other 2. Then administration of the PDE5 inhibitor was followed, which produced satisfactory efficacy. One case was treated with oral bromocriptine, which restored the prolactin level to nor- mal at 12 months ( IIEF-5 〉 21 ). Conclusion. Prolactin detection and brain MRI can help to confirm pituitary prolactinoma with se- vere ED at the onset. As for its treatment, in case of an extremely high level of prolactin, simple administration of the PDE5 inhibitor is ineffective. When the prolactin level is reduced after surgery or medication, the symptom of ED can be improved and, in case of no obvious relief, administration of the PDE5 inhibitor can be followed, which may achieve satisfactory results.
出处 《中华男科学杂志》 CAS CSCD 2013年第2期141-143,共3页 National Journal of Andrology
关键词 垂体泌乳素瘤 勃起功能障碍 溴隐亭 5型磷酸二酯酶抑制剂 治疗 pituitary prolactinoma erectile dysfunction bromocriptine PDE5 inhibitor treatment
  • 相关文献

参考文献9

  • 1Vallette-Kasic S, Morange-Ramos I, Selim A, et al. Macropro- lactinemia revisited: A study on 106 patients. J Clin Endocrinol Metab, 2002, 87(2): 581-588. 被引量:1
  • 2Strachan MW, Teoh W. Clinical and radiological feature of pa- tients with maroprolactinaemia. Clin Endocrinol, 2003, 59 ( 3 ) : 339-346. 被引量:1
  • 3Buvat J. Hyperprolactinemia and sexual function in men: A short review. Int J Impot Res, 2003, 15(5) : 373-377. 被引量:1
  • 4Schneider W, Marcovitz S, A1-Shammari S, et al. Reactivity of macroprolactin in common automated immunoassays. Clin Bio- chem, 2001, 34(6) : 469-473. 被引量:1
  • 5Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med, 2010, 363(2): 123-135. 被引量:1
  • 6王涛,李士其,黄中.经蝶手术对男性青壮年垂体泌乳素腺瘤患者性腺功能的影响(附70例分析).中国临床神经学杂志,2010,18(2):173-178. 被引量:1
  • 7商学军,黄宇烽.西地那非在中国男科临床应用十年回顾[J].中华男科学杂志,2012,18(8):742-746. 被引量:9
  • 8Hwang TI, Chen HE, Tsai TF, et al. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone. Int J Impot Res, 2006, 18(4) : 400-404. 被引量:1
  • 9Garcia JA, Sanchez PE, Fraile C, et al. Testosterone undecano- ate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone. Andrologia, 2011,43(5) : 293-296. 被引量:1

二级参考文献43

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部